# Bupivacaine Versus Lidocaine on Inflammatory Regulation

> **NCT01060774** · PHASE4 · COMPLETED · sponsor: **University of Maryland** · enrollment: 11 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT01060774
- **Lead sponsor:** University of Maryland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-07
- **Final completion:** 2010-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060774, "Bupivacaine Versus Lidocaine on Inflammatory Regulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01060774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*